These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28929324)

  • 1. Stress Ulcer Prophylaxis in Neurocritical Care.
    Barletta JF; Mangram AJ; Sucher JF; Zach V
    Neurocrit Care; 2018 Dec; 29(3):344-357. PubMed ID: 28929324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
    Hong MT; Monye LC; Seifert CF
    Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
    BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress Ulcer Prophylaxis.
    Barletta JF; Bruno JJ; Buckley MS; Cook DJ
    Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM; MacLaren R
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
    Barletta JF; Sclar DA
    Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
    He N; Yan Y; Su S; Ge Q; Zhai S
    Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
    Cook D; Guyatt G
    N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
    [No Abstract]   [Full Text] [Related]  

  • 11. Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding.
    Sochet AA; Son S; Ryan KS; Roddy M; Barrie E; Wilsey M; McKinley SD; Nakagawa TA
    J Asthma; 2020 Aug; 57(8):858-865. PubMed ID: 31046509
    [No Abstract]   [Full Text] [Related]  

  • 12. Stress ulcer prophylaxis versus placebo-a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD).
    Mills KI; Albert BD; Bechard LJ; Duggan CP; Kaza A; Rakoff-Nahoum S; Vlamakis H; Sleeper LA; Newburger JW; Priebe GP; Mehta NM
    Trials; 2020 Jun; 21(1):590. PubMed ID: 32600393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
    Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
    J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
    Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
    Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic acid suppression and enteral nutrition.
    Barletta JF
    Curr Opin Clin Nutr Metab Care; 2023 Mar; 26(2):174-178. PubMed ID: 36892963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.
    Mekhail A; Young P; Mekhail AM; Tinawi G; Haran C; Clayton N; Galvin S
    J Intensive Care Med; 2023 Oct; 38(10):917-921. PubMed ID: 37093762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
    Boyd C; Hassig T; MacLaren R
    Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-related mucosal bleeding in critically ill oncology patients.
    Bruno JJ; Canada TW; Wakefield CD; Nates JL
    J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.